Commonwealth Numbered Regulations

1980 No. 69 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENTS) - SCHEDULE 4

SCHEDULE 4
Regulation 5 AMENDMENTS OF SCHEDULE 5 TO THE NATIONAL HEALTH (PHARMACEUTICAL
BENEFITS) REGULATIONS

1. Omit Item 36, substitute the following items:

    "36      Chlormethiazole . . . . . .   With the written authority of the
Permanent Head-
Short-term hospital use for
alcohol or drug withdrawal therapy
Status epilepticus
    "36A     Chlormethiazole Edisylate .   Short-term hospital use for alcohol
or drug withdrawal therapy
Status epilepticus".

2. Omit Item 52, substitute the following item:

    "52      Danazol . . . . . . . . . .   With the written authority of the
Permanent Head-
Endometriosis proven by
laparoscopy or laparotomy
Hereditary angio-oedema".

3. Omit Item 91, substitute the following item:

    "91      Influenza Vaccine . . . . .   Prophylaxis of persons at special
risk of adverse consequences from
infections of the lower respiratory
tract".

4. Omit Item 108, substitute the following item:

    "108     (1) Methadone Injection,
B.P.
              (2) Methadone Tablets, B.P.   Disabling pain associated with

proven malignant neoplasia
Disabling pain associated with
self-limiting disorders of short
duration not responding to
non-narcotic analgesics, the maximum duration of treatment being two
weeks".

5. Omit Item 136, substitute the following item:

    "136     (1) Pancreatin   Enzyme
              4X  U.S.N.F. XIII strength    Cystic fibrosis (mucoviscidosis)
Following pancreatico-duodenectomy
              (2) Pancreatin   Enzyme

              5X  U.S.N.F. XIV strength     Pancreatic steatorrhoea".


(3) Pancrelipase

6. Omit Item 138, substitute the following item:

    "138     Pentazocine Lactate
              Injection, B.P. . . . . . .   Disabling pain associated with
proven malignant neoplasia
Disabling pain associated with
self-limiting disorders of short
duration not responding to
non-narcotic analgesics, the maximum duration of treatment being two
weeks".

7. After Item 161 insert the following item:

    "161A    Pyrimethamine, B.P. with
              Sulfadoxine                   Prophylaxis or treatment of
chloroquine-resistant falciparum
malaria only".

8. Omit Item 190, substitute the following items:

    "190     Verapamil Hydrochloride
              Injection . . . . . . . . .   Cardiac arrhythmias
    "190A    Verapamil Hydrochloride
              Tablets . . . . . . . . . .   With the written authority of the
Permanent Head-
Angina at rest (Prinzmetal) in
patients who are not taking a beta
blocking drug
Angina associated with respiratory disease in patients who are not
taking a beta blocking drug
Cardiac arrhythmias in patients
who are not taking a beta blocking
drug".